4577 — Daito Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual balance sheet for Daito Pharmaceutical, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2022 May 31st	2023 May 31st	2024 May 31st	2025 May 31st	2026 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4,381	3,607	2,727	2,207	954
Net Total Accounts Receivable
Net Total Receivables	16,146	17,654	16,733	20,254	18,955
Total Inventory
Total Other Current Assets
Total Current Assets	37,909	40,663	41,460	41,708	36,629
Net Property, Plant And Equipment	23,116	25,837	31,972	31,826	30,676
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	64,939	70,552	77,708	78,004	73,291
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,069	15,428	18,505	17,049	13,998
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	17,632	19,880	25,639	26,001	20,399
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	47,307	50,672	52,069	52,003	52,892
Total Liabilities & Shareholders' Equity	64,939	70,552	77,708	78,004	73,291
Total Common Shares Outstanding